Publication | Closed Access

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringBlood–brain BarrierMedicineTherapeutic NanomaterialsDrug Delivery SystemsNano-drug DeliveryBiomedical EngineeringPharmacologyNeuroimmunology